PQ 672
672. Deputy Shay Brennan asked the Minister for Health if she is aware of concerns that some people living with Friedreich’s ataxia may face significant delays in accessing skyclarys (omaveloxolone) despite its reimbursement from 1 October 2026 (details supplied); the estimated timeframe within which all eligible patients will have commenced treatment; if additional resources will be provided to support treatment initiation and monitoring; the current waiting time for a Friedreich’s ataxia clinic appointment; and the measures being taken to address access to timely specialist review and annual multidisciplinary assessments. [70468/26]
Introduced
6 October 2026
Last action
6 October 2026 · Medicinal Products
Status
written
Sponsors
Shay Brennan
Subjects
Discovery layer
Source updated
6 October 2026
Summary
672. Deputy Shay Brennan asked the Minister for Health if she is aware of concerns that some people living with Friedreich’s ataxia may face significant delays in accessing skyclarys (omaveloxolone) despite its reimbursement from 1 October 2026 (details supplied); the estimated timeframe within which all eligible patients will have commenced treatment; if additional resources will be provided to support treatment initiation and monitoring; the current waiting time for a Friedreich’s ataxia clinic appointment; and the measures being taken to address access to timely specialist review and annual multidisciplinary assessments. [70468/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
6 October 2026
Medicinal Products
672. Deputy Shay Brennan asked the Minister for Health if she is aware of concerns that some people living with Friedreich’s ataxia may face significant delays in accessing skyclarys (omaveloxolone) despite its reimbursement from 1 October 2026 (details supplied); the estimated timeframe within which all eligible patients will have commenced treatment; if additional resources will be provided to support treatment initiation and monitoring; the current waiting time for a Friedreich’s ataxia clinic appointment; and the measures being taken to address access to timely specialist review and annual multidisciplinary assessments. [70468/26]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Medicinal Products
xml · EN · 6 October 2026
Sponsors
- Shay Brennan · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-10-06/672/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-10-06/pq_672
- ireland · q-2026-10-06-pq_672 · source updated 6 October 2026